PMH76 - PATIENT REPORTED MEASURES OF DEPRESSIVE SYMPTOMS AND FATIGUE IN A PHASE 2, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF THE GABAA RECEPTOR POSITIVE ALLOSTERIC MODULATOR SAGE-217 IN MAJOR DEPRESSIVE DISORDER
Abstract
Authors
V. Bonthapally E. Suthoff P. Hodgkins H. Gunduz-Bruce R. Lasser C. Silber A. Sankoh H. Li J. Jonas J. Doherty S. Kanes